Your browser doesn't support javascript.
loading
Weight Maintenance up to 48 Weeks in Patients With Carcinoid Syndrome Treated With Telotristat Ethyl: Pooled Data From the Open-Label Extensions of the Phase III Clinical Trials TELESTAR and TELECAST.
Srirajaskanthan, Rajaventhan; Pavel, Marianne; Kulke, Matthew; Clement, Dominique; Houchard, Aude; Keeber, Lucie; Weickert, Martin O.
Afiliação
  • Srirajaskanthan R; Neuroendocrine Tumour Unit, ENETS, Centre of Excellence, Institute of Liver Studies, King's College Hospital, London, United Kingdom. Electronic address: r.srirajaskanthan@nhs.net.
  • Pavel M; Department of Medicine 1, Division of Endocrinology, Friedrich Alexander University Erlangen-Nürnberg, Erlangen, Germany.
  • Kulke M; Section of Hematology and Oncology, Boston University and Boston Medical Center, Boston, Massachusetts.
  • Clement D; Neuroendocrine Tumour Unit, ENETS, Centre of Excellence, Institute of Liver Studies, King's College Hospital, London, United Kingdom.
  • Houchard A; Ipsen, Boulogne-Billancourt, France.
  • Keeber L; Ipsen, Slough, United Kingdom.
  • Weickert MO; The ARDEN NET Centre, ENETS Centre of Excellence, University Hospitals Coventry and Warwickshire, National Health Service Trust, Coventry, United Kingdom.
Clin Ther ; 43(10): 1779-1785, 2021 10.
Article em En | MEDLINE | ID: mdl-34598813
Assuntos
Palavras-chave
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Síndrome do Carcinoide Maligno Limite: Humans Idioma: En Revista: Clin Ther Ano de publicação: 2021 Tipo de documento: Article
Texto completo
Imprimir
XML
PubMed Links
Buscar no Google

Texto completo: 1 Coleções: 01-internacional Base de dados: MEDLINE Assunto principal: Qualidade de Vida / Síndrome do Carcinoide Maligno Limite: Humans Idioma: En Revista: Clin Ther Ano de publicação: 2021 Tipo de documento: Article